首页> 外国专利> n - and c - terminal peptide selection method for proteomics

n - and c - terminal peptide selection method for proteomics

机译:蛋白质组学的n和c端肽选择方法

摘要

Reducing (M1) the complexity of a proteomic sample, and preferably identifying proteins in the sample, comprises protecting the protein N- or C-termini with a suitable protecting agent, cleaving the protected proteins, separating the protected peptides from the peptide mixture, to reduce the sample complexity to one terminal peptide per sample protein, and, optionally, detecting the terminally protected peptides. Reducing (M1) the complexity of a proteomic sample, and preferably identifying proteins in the sample, comprises: (a) providing one or more proteins; (b) protecting the protein N- or C-termini with a suitable protecting agent; (c) cleaving the terminally protected proteins with a suitable cleaving agent to produce a mixture of terminally protected peptides and non-terminally protected peptides comprising free amino and carboxyl groups corresponding to the cleavage sites; (d) separating the terminally protected peptides from the peptide mixture, to reduce the sample complexity to one terminal peptide per sample protein; and, optionally (e) detecting the terminally protected peptides. Independent claims are also included for: (1) quantitatively comparing (M2) protein levels in two or more proteomic samples, comprising: (a) providing two or more samples each containing one or more proteins; (b) carrying out steps (b)-(d) of (M1), for each sample, thus reducing the sample complexity for each of the two or more protein samples to one terminal peptide per sample protein; (c) differentially labeling the terminally protected peptides of each sample with a suitable reagent comprising a detectable label, to generate two or more sets of differentially labeled terminal peptides; (d) measuring the relative levels of the differentially labeled terminal peptides, having optionally first combined the sets of labeled peptides; (2) a kit (II) for identifying proteins in a proteomic sample comprising one or more protecting agents for protecting the N- or C-termini, one or more cleaving agents, and means for separating the N- or C-terminally protected peptides from the mixture; and (3) a proteomic sample of reduced complexity obtainable by (M1).
机译:降低(M1)蛋白质组样品的复杂性,并优选鉴定样品中的蛋白质,包括用合适的保护剂保护蛋白质N-末端或C-末端,切割受保护的蛋白质,将受保护的肽与肽混合物分离,从而将样品的复杂性降低到每个样品蛋白质一个末端肽,并可选地检测末端保护的肽。降低(M1)蛋白质组学样品的复杂性,并优选鉴定样品中的蛋白质,包括:(a)提供一种或多种蛋白质; (b)用合适的保护剂保护蛋白质N-末端或C-末端; (c)用合适的裂解剂裂解末端保护的蛋白质,以产生末端保护的肽和包含对应于裂解位点的游离氨基和羧基的非末端保护的肽的混合物; (d)从肽混合物中分离末端保护的肽,以将样品复杂性降低到每个样品蛋白质一个末端肽;以及,任选地(e)检测末端保护的肽。还包括以下独立权利要求:(1)定量比较两个或更多个蛋白质组样品中的(M2)蛋白水平,包括:(a)提供两个或更多个样品,每个样品均包含一种或多种蛋白; (b)对每个样品进行(M1)的步骤(b)-(d),从而将两个或更多个蛋白样品中的每个样品的样品复杂度降低到每个样品蛋白一个末端肽; (c)用包含可检测标记的合适试剂对每个样品的末端保护肽进行差异标记,以产生两组或多组差异标记的末端肽; (d)测量差异标记的末端肽的相对水平,任选地首先组合标记的肽组; (2)用于鉴定蛋白质组样品中蛋白质的试剂盒(II),其包含一种或多种用于保护N末端或C末端的保护剂,一种或多种裂解剂以及分离N末端或C末端被保护的肽的手段从混合物中(3)可通过(M1)获得的复杂性降低的蛋白质组学样本。

著录项

  • 公开/公告号DE60320207D1

    专利类型

  • 公开/公告日2008-05-21

    原文格式PDF

  • 申请/专利权人 AGILENT TECHNOLOGIES INC.;

    申请/专利号DE2003620207T

  • 发明设计人 FISCHER STEVEN M.;

    申请日2003-12-04

  • 分类号G01N27/62;G01N33/68;C07K1/36;C12Q1/37;G01N27/64;G01N31/22;G01N33/58;

  • 国家 DE

  • 入库时间 2022-08-21 19:47:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号